Showing results (321-330 of 5,984) with videos related to

Sort By:
Pageof 599
Molecular Cancer Therapeutics|May 31, 2013
Preclinical evaluation of transcriptional targeting strategy for human hepatocellular carcinoma in an orthotopic xenograft mouse modelKian Chuan Sia, Hung Huynh, Alexander Yaw Fui Chung, et al.
Molecular Cancer Therapeutics|June 13, 2013
Modulation of OATP1B-type transporter function alters cellular uptake and disposition of platinum chemotherapeuticsCynthia S Lancaster, Jason A Sprowl, Aisha L Walker, et al.
Molecular Cancer Therapeutics|April 30, 2013
Small-molecule inhibitors of acetyltransferase p300 identified by high-throughput screening are potent anticancer agentsHeng Yang, Christie E Pinello, Jian Luo, et al.
Molecular Cancer Therapeutics|May 3, 2013
Impact of tumor vascularity on responsiveness to antiangiogenesis in a prostate cancer stem cell-derived tumor modelKexiong Zhang, David J Waxman
Molecular Cancer Therapeutics|March 29, 2013
Expression of leukemia-associated fusion proteins increases sensitivity to histone deacetylase inhibitor-induced DNA damage and apoptosisLuca A Petruccelli, Filippa Pettersson, Sonia V Del Rincón, et al.
Molecular Cancer Therapeutics|June 21, 2013
An autocrine loop between TGF-β1 and the transcription factor brachyury controls the transition of human carcinoma cells into a mesenchymal phenotypeCecilia Larocca, Joseph R Cohen, Romaine I Fernando, et al.
Molecular Cancer Therapeutics|June 2, 2012
Oxidative stress induced by curcumin promotes the death of cutaneous T-cell lymphoma (HuT-78) by disrupting the function of several molecular targetsMohammad Aslam Khan, Satindra Gahlot, Sekhar Majumdar
Molecular Cancer Therapeutics|June 2, 2012
Characterization of the mechanism of action of the pan class I PI3K inhibitor NVP-BKM120 across a broad range of concentrationsSaskia M Brachmann, Julia Kleylein-Sohn, Swann Gaulis, et al.
Molecular Cancer Therapeutics|June 2, 2012
The checkpoint kinase inhibitor AZD7762 potentiates chemotherapy-induced apoptosis of p53-mutated multiple myeloma cellsHeather J Landau, Samuel C McNeely, Jayasree S Nair, et al.
Molecular Cancer Therapeutics|June 13, 2012
A small-molecule inhibitor of glucose transporter 1 downregulates glycolysis, induces cell-cycle arrest, and inhibits cancer cell growth in vitro and in vivoYi Liu, Yanyan Cao, Weihe Zhang, et al.
Pageof 599